Literature DB >> 27929275

Erectile Dysfunction.

Karl T Rew1, Joel J Heidelbaugh1.   

Abstract

Erectile dysfunction (ED) is the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It is common, affecting at least 12 million U.S. men. The five-question International Index of Erectile Function allows rapid clinical assessment of ED. The condition can be caused by vascular, neurologic, psychological, and hormonal factors. Common conditions related to ED include diabetes mellitus, hypertension, hyperlipidemia, obesity, testosterone deficiency, and prostate cancer treatment. Performance anxiety and relationship issues are common psychological causes. Medications and substance use can cause or exacerbate ED; antidepressants and tobacco use are the most common. ED is associated with an increased risk of cardiovascular disease, particularly in men with metabolic syndrome. Tobacco cessation, regular exercise, weight loss, and improved control of diabetes, hypertension, and hyperlipidemia are recommended initial lifestyle interventions. Oral phosphodiesterase-5 inhibitors are the firstline treatments for ED. Second-line treatments include alprostadil and vacuum devices. Surgically implanted penile prostheses are an option when other treatments have been ineffective. Counseling is recommended for men with psychogenic ED.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27929275

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  13 in total

1.  Re: Intraoperative intracavernosal liposomal bupivacaine (Exparel) injection does not affect systemic hemodynamics.

Authors:  Soum D Lokeshwar; Sarrah L Hasanali; Daley S Morera; Joshua Bitran; Ranjith Ramasamy
Journal:  Int J Impot Res       Date:  2020-03-20       Impact factor: 2.896

2.  A systematic review and evidence-based analysis of ingredients in popular male testosterone and erectile dysfunction supplements.

Authors:  Manish Kuchakulla; Manish Narasimman; Yash Soni; Joon Yau Leong; Premal Patel; Ranjith Ramasamy
Journal:  Int J Impot Res       Date:  2020-05-01       Impact factor: 2.896

Review 3.  Availability of platelet-rich plasma for treatment of erectile dysfunction and associated costs and efficacy: A review of current publications and Canadian data.

Authors:  Deron Britt; Udi Blankstein; Matthew Lenardis; Alexandra Millman; Ethan Grober; Yonah Krakowsky
Journal:  Can Urol Assoc J       Date:  2021-06       Impact factor: 1.862

Review 4.  Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis.

Authors:  Binbin Gong; Ming Ma; Wenjie Xie; Xiaorong Yang; Yongming Huang; Ting Sun; Yanping Luo; Jiao Huang
Journal:  Int Urol Nephrol       Date:  2017-07-24       Impact factor: 2.370

Review 5.  Erectile Dysfunction: A Primer for in Office Management.

Authors:  Samir Sami; Noah Stern; Andrew Di Pierdomenico; Brandon Katz; Gerald Brock
Journal:  Med Sci (Basel)       Date:  2019-08-29

6.  Erectile Dysfunction Preceding Clinically Diagnosed α-Synucleinopathies: A Case-Control Study in Olmsted County.

Authors:  Shemonti Hasan; Michelle M Mielke; J Eric Ahlskog; James Bower; Pierpaolo Turcano; Rodolfo Savica
Journal:  Parkinsons Dis       Date:  2019-04-09

7.  A correlation study of ischiocavernosus muscle injury with different types of pelvic fractures and erectile dysfunction after pelvic fracture.

Authors:  Zongping Chen; Tao Song; Yongxiang Zhuang; Yong Yan; Tong Liu; Kaiyi Mao; Xu Li; Chenghong Zou; Xin Wen; Yuhong Yao; Chao Chen; Sicong Zhao
Journal:  OTA Int       Date:  2020-09-16

8.  The relationships between bariatric surgery and sexual function: current evidence based medicine.

Authors:  Shengzhuo Liu; Dehong Cao; Zhengju Ren; Jinze Li; Lei Peng; Qin Zhang; Bo Cheng; Zheyu Cheng; Jianzhong Ai; Xiaonan Zheng; Liangren Liu; Qiang Wei
Journal:  BMC Urol       Date:  2020-10-02       Impact factor: 2.264

9.  Spanish Cross-Cultural Validation of the Electronic Version of the International Index of Erectile Function-5 (IIEF-5).

Authors:  Raquel Lizarraga-Limousin; Esther M Medrano-Sánchez; Esther Díaz-Mohedo; Lorena Vergara-de-Carlos
Journal:  Int J Environ Res Public Health       Date:  2022-03-07       Impact factor: 3.390

10.  Evaluation of immediate and short-term efficacy of DualStim therapy with and without intracavernosal umbilical cord-derived Wharton's jelly in patients with erectile dysfunction: Study protocol for a randomized controlled trial.

Authors:  Ashim Gupta; Hugo C Rodriguez; Kristin Delfino; Howard J Levy; Saadiq F El-Amin; Richard Gaines
Journal:  Contemp Clin Trials Commun       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.